|
|
|
|
Implementing the gains in cancer prevention
Cancer is now the leading cause of death among Americans younger than 65 years. That statement is less alarming than it first appears, because deaths attributable to heart disease dropped dramatically in recent years. In fact, the number of cancer deaths has also fallen during the same period, but less rapidly than heart disease deaths.
|
| |
More>>
|
|
|
|
|
|
Early cancer diagnosis: Present and future
For many cancers, earlier diagnosis and earlier detection of recurrence could have a profound impact on survival rates and maximize positive outcomes. Concurrent with ongoing efforts to identify new, more effective diagnostic tools is an emphasis on developing methods of diagnosing cancer that are minimally invasive, cost effective, easy to use, require little training or technical skill, and are amenable to use in an office-based or clinical laboratory setting.
|
| |
More>>
|
|
|
|
|
|
Updates in colon, cervical, breast, and prostate cancer screening
Although minor differences among organizations still exist, major guidelines for colon, cervical, and breast screening and for testing for early prostate cancer screening are quite similar. Even so, a large subset of the general population either continues to go unscreened or is screened inconsistently. For example, few men and women (fewer than 30%) reported the recent use of any colorectal screening test in 2000.
|
| |
More>>
|
|
|
|
|
|
Using aromatase inhibitors to induce ovulation in breast Ca survivors
This article looks at aromatase inhibitors as potential alternatives to clomiphene citrate and gonadotropins for stimulating fertility in breast cancer survivors.
|
| |
More>>
|
|
|
We subscribe to the HONcode principles of the Health On the Net Foundation